Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

35.52
+0.14500.41%
Volume:94.75K
Turnover:3.42M
Market Cap:915.53M
PE:-0.25
High:37.44
Open:36.56
Low:35.12
Close:35.37
52wk High:42.14
52wk Low:7.45
Shares:25.78M
Float Shares:811.70K
Volume Ratio:0.56
T/O Rate:11.67%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-141.6499
EPS(LYR):-16.7239
ROE:-195.26%
ROA:-20.79%
PB:5.29
PE(LYR):-2.12

Loading ...

Faeth Therapeutics Files Initial Beneficial Ownership Statement for Khosla Ventures VI, L.P

Reuters
·
Jul 29

Faeth Therapeutics' Experimental Cancer Drug Piktor Has Upside Potential, Oppenheimer Says

MT Newswires Live
·
Jul 28

Faeth Therapeutics, Inc : Oppenheimer Initiates Coverage with Outperform Rating; Price Target $60

THOMSON REUTERS
·
Jul 28

Oppenheimer Initiates Faeth Therapeutics at Outperform

MT Newswires Live
·
Jul 28

Faeth Therapeutics initiated with an Outperform at Oppenheimer

TIPRANKS
·
Jul 28

Faeth Therapeutics Adopts Performance-Based Stock Option Plan

TIPRANKS
·
Jul 24

Faeth Therapeutics Grants New-hire Stock Options for 25,500 Shares at $28.19 Each

Reuters
·
Jul 24

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 24

Faeth Therapeutics Initiated at Market Outperform by Citizens

Dow Jones
·
Jul 20

Faeth Therapeutics Price Target Maintained with a $55.00/share by BTIG

Dow Jones
·
Jul 16

Faeth Therapeutics, Inc trading halted, volatility trading pause

TIPRANKS
·
Jul 16

NASDAQ Trade Halt Volatility Trading Pause at 03:31 Pm

Reuters
·
Jul 16

Faeth Therapeutics Grants New-hire Inducement Stock Options for 180,350 Shares

Reuters
·
Jul 04

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 04

Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)

TIPRANKS
·
Jul 03

Faeth Therapeutics CFO Brian C. Stephenson Acquires USD 319,293 of Common Shares

Reuters
·
Jul 02

Faeth Therapeutics CFO Makes Bold Insider Move With Fresh Share Purchase

TIPRANKS
·
Jun 27

Faeth Therapeutics CFO Brian C. Stephenson Reports $489,159 Common Share Purchase

Reuters
·
Jun 27

Faeth Therapeutics Initiated at Outperform by Baird

Dow Jones
·
Jun 26

Baird Initiates Faeth Therapeutics at Outperform With $57 Price Target

MT Newswires Live
·
Jun 26